Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration

Dysregulation of clusterin (CLU) has been demonstrated in many cancers and has been proposed as a regulator of carcinogenesis. However, the roles of CLU in gliomas remain unclear. The expression of CLU was assessed using TIMER2.0, GEPIA2, and R package 4.2.1 software, leveraging data from TCGA and/o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiaoyue, Chang, Chao, Qi, Teng, Yang, Pengyu, Wang, Yuanbo, Zhou, Xiaorui, Guan, Feng, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487477/
https://www.ncbi.nlm.nih.gov/pubmed/37686218
http://dx.doi.org/10.3390/ijms241713413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487477/
https://www.ncbi.nlm.nih.gov/pubmed/37686218
http://dx.doi.org/10.3390/ijms241713413

Ejemplares similares